Economic Intelligence Brief No. 17 — Data as of July 10, 2026
The Exit File: Sales, Mergers & Public Listings of U.S. Regulation Crowdfunding Companies
Crowdfunded companies are exiting — $6.1B in sales, mergers and public listings in just fourteen months.
$6.1B — verified Reg CF liquidity-event value, May 2025–June 2026
Summary
Ten years in, Regulation Crowdfunding has crossed from promising to producing institutional-scale exits. Between May 2025 and June 2026, crowdfunding-born companies generated roughly $6.1 billion in verified liquidity-event value: a $177 million cash acquisition by NYSE-listed Zimmer Biomet (up to $747 million with milestone payments), a $1.6 billion NYSE listing, a $3.5 billion SPAC combination approved by shareholders, and two Nasdaq direct listings. This brief verifies the exit record against SEC filings, tracks outcomes honestly — including wind-downs and post-IPO losses — and shows why every commercial database is either blind to this market or mislabeling it.
Key findings
- Seven of the ten most significant verified Reg CF exits closed between May 2025 and June 2026 — the 2016–2019 vintages are just entering the 7–10 year window where venture outcomes concentrate.
- Monogram Technologies, seeded by retail crowdfunding investors in 2019, was acquired by Zimmer Biomet for $4.04 per share in cash plus contingent value rights of up to $12.37 per share — approximately $177 million upfront and up to $747 million in total consideration.
- BOXABL's shareholder-approved SPAC merger at a $3.5 billion deemed valuation converts more than 50,000 crowdfunding investors into Nasdaq shareholders — the largest crowd-to-public conversion on record, which Crunchbase labels simply "Acquired."
- Crowd-to-public is the signature Reg CF exit path: Angel Studios (NYSE at $1.6B), Aptera and Turn Therapeutics (Nasdaq direct listings), and others converted tens of thousands of retail shareholders into public-market investors.
- The record is reported honestly: roughly 2% of funded Reg CF companies have reached a liquidity event to date, and failures such as NowRx's wind-down are tracked at equal resolution — because base rates are the product.
Frequently asked questions
How much Reg CF exit value closed in the last fourteen months?
Roughly $6.1 billion in verified liquidity-event value between May 2025 and June 2026, spanning a NYSE-listed acquirer's cash-plus-CVR takeover, a $1.6B NYSE listing, a $3.5B SPAC combination approved by shareholders, and two Nasdaq direct listings.
What share of funded Reg CF companies have reached a liquidity event?
Roughly 2% to date. The Exit File tracks both exits and failures — including wind-downs like NowRx — at equal resolution, because base rates are the product.
Why don't commercial databases show this?
Every commercial database is either blind to the Reg CF market or mislabeling it. BOXABL's $3.5B SPAC combination, for example, is filed on Crunchbase simply as "Acquired." The Exit File verifies each event directly against SEC filings.
Audience
Investors & Data Buyers
About this brief
Published by CCLEAR.ai. Anchored to public SEC EDGAR filings and hand-verified against a locked data snapshot. CCLEAR is a data publisher, not an investment adviser; figures describe market activity, not investment outcomes or advice.
The Exit File: Sales, Mergers & Public Listings of U.S. Regulation Crowdfunding Companies · CCLEAR Research Library · License the data · Commission research
More briefs in the CCLEAR Research Library